Cardiovascular Disease Mortality in Belgrade: Trends from 1975-89
Overview
Affiliations
Study Objective: To determine trends in cardiovascular disease mortality.
Design: This was a descriptive study analysing mortality data.
Setting: Belgrade, Yugoslavia.
Participants: The population of Belgrade in the age group 30-69 years was studied (about 760,000 inhabitants).
Measurements: Mortality rates were standardised directly using those of the "European population" as the standard, and regression analysis was undertaken.
Main Results: Between 1975 and 1989 "all causes" mortality increased by 27% (95% confidence interval 18.5, 35.9) in men and by 19% (11.6, 27.1) in women. The increase in cardiovascular disease mortality was 7% (1.7, 11.5) for men and 4% (0.2, 7.8) for women. Mortality from ischaemic heart disease fell in both sexes by 32% (23.0, 41.0), but mortality from other heart diseases rose by 31% (22.0, 40.2) in men and 25% (16.2, 33.0) in women. In men the death rate for cerebrovascular disease increased by 37% (27.8, 46.8), but in women the rate fell by 0.4% (-0.8, 1.6). Mortality from the observed causes of death was higher in men than in women.
Conclusion: Cardiovascular mortality trends in Belgrade are similar to those in most eastern European countries. If the distribution of cigarette smoking and a "rich" diet in the Belgrade population is taken into account, a considerable decline in cardiovascular mortality trends cannot be expected in the near future.
Trends in cerebrovascular diseases mortality in Serbia, 1997-2016: a nationwide descriptive study.
Ilic I, Ilic M, Sipetic Grujicic S BMJ Open. 2019; 9(2):e024417.
PMID: 30782903 PMC: 6398636. DOI: 10.1136/bmjopen-2018-024417.
Maksimovic M, Vlajinac H, Radak D, Maksimovic J, Marinkovic J, Jorga J Croat Med J. 2008; 49(6):824-31.
PMID: 19090608 PMC: 2621020. DOI: 10.3325/cmj.2008.49.824.
The making and breaking of Yugoslavia and its impact on health.
Kunitz S Am J Public Health. 2004; 94(11):1894-904.
PMID: 15514224 PMC: 1448556. DOI: 10.2105/ajph.94.11.1894.